SS
Shachar Shlosberger at Enlivex Therapeutics (NAS: ENLV)
Developer of a clinical stage immunotherapy platform designed to treat autoimmune and inflammatory conditions
ContactFirm
Enlivex Therapeutics (NAS: ENLV)
Location
Global
Investment Stage
Growth
Geographic Focus
Global
About Shachar Shlosberger
Enriching content...
Similar Investors in Global
Contact Enlivex Therapeutics (NAS: ENLV)
Get in touch for investment criteria and partnership opportunities.
Contact